Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.020
-0.050 (-4.67%)
Mar 6, 2026, 9:54 AM EST - Market open
Citius Oncology Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Selling, General & Admin | 18.79 | 17.1 | 15.65 | 7.88 | 2.86 |
| Research & Development | 6.17 | 6.42 | 4.93 | 4.24 | 6.86 |
| Operating Expenses | 25.53 | 23.52 | 20.57 | 12.12 | 9.71 |
| Operating Income | -22.38 | -23.52 | -20.57 | -12.12 | -9.71 |
| Interest Expense | -0.26 | -0.22 | - | - | - |
| Interest & Investment Income | 0.06 | 0.04 | - | - | - |
| Pretax Income | -22.58 | -23.7 | -20.57 | -12.12 | -9.71 |
| Income Tax Expense | 1.06 | 1.06 | 0.58 | 0.58 | 1.15 |
| Net Income | -23.64 | -24.76 | -21.15 | -12.7 | -10.87 |
| Net Income to Common | -23.64 | -24.76 | -21.15 | -12.7 | -10.87 |
| Shares Outstanding (Basic) | 77 | 73 | 68 | 68 | 34 |
| Shares Outstanding (Diluted) | 77 | 73 | 68 | 68 | 34 |
| Shares Change (YoY) | 11.84% | 7.66% | 0.82% | 100.00% | - |
| EPS (Basic) | -0.31 | -0.34 | -0.31 | -0.19 | -0.32 |
| EPS (Diluted) | -0.31 | -0.34 | -0.31 | -0.19 | -0.32 |
| EBIT | -22.38 | -23.52 | -20.57 | -12.12 | -9.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.